Allergen, Individual-Grass pollen Sweet Vernal Anthoxanthum Odoratum G1

The Allergen, Individual‑Grass pollen Sweet Vernal (Anthoxanthum odoratum) G1 test measures specific IgE antibodies directed against Sweet Vernal grass pollen using a validated immunoassay on a blood sample collected at home by a trained phlebotomist. It identifies sensitisation to this common grass pollen, helping to pinpoint the cause of seasonal rhinitis, conjunctivitis or pollen‑triggered asthma.

This test is useful for patients with seasonal respiratory or ocular symptoms suggestive of grass pollen allergy, for clinicians planning allergen avoidance strategies or considering allergen immunotherapy, and for monitoring sensitisation patterns. Results are reported in standardized units (kU/L) with interpretive categories; positive findings should be correlated with clinical history and local pollen exposure in Dubai, and discussed with an allergy specialist as needed.

• Sweet Vernal (Anthoxanthum odoratum) — Specific IgE (G1)
• Specific IgE concentration (kU/L)
• Qualitative result category (Negative/Equivocal/Positive)
• Allergen code: G1

• During recurrent seasonal sneezing, nasal congestion or itchy eyes in grass seasons
• When symptoms worsen after exposure to lawns, parks or grassy fields
• Prior to starting or selecting allergen immunotherapy for grass pollen
• Uncontrolled asthma with seasonal exacerbations coinciding with grass pollen peaks
• To distinguish sensitisation to Sweet Vernal from other regional pollen allergens

• Accurate identification of sensitisation to Sweet Vernal grass pollen
• Supports targeted avoidance measures and personalised treatment plans
• Helpful for deciding on suitability and formulation of immunotherapy
• Convenient home collection across Dubai, reducing clinic visits
• Standardised laboratory reporting compatible with UAE clinical care

• Home blood sample collection (venous or capillary) by trained phlebotomist
• No fasting required before sample collection
• Inform provider about recent allergen immunotherapy or biologic treatments
• Provide recent symptom history and typical exposure locations for accurate interpretation